{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:44:46Z","timestamp":1763660686210,"version":"3.45.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,20]]},"DOI":"10.7759\/cureus.97344","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:32:17Z","timestamp":1763659937000},"source":"Crossref","is-referenced-by-count":0,"title":["Anti-synthetase Syndrome Presenting Primarily as Interstitial Lung Disease in a Young Adult: A Diagnostic Challenge in Acute Medicine"],"prefix":"10.7759","author":[{"given":"Kawser","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faaraan","family":"Bangash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arsalan","family":"Bangash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaseen","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/8xj0b9","article-title":"Defining anti-synthetase syndrome: a systematic literature review","volume":"40","author":"Zanframundo G","year":"2022","unstructured":"Zanframundo G, Faghihi-Kashani S, Scir\u00e8 CA, et al.. Defining anti-synthetase syndrome: a systematic literature review. Clin Exp Rheumatol. 2022, 40:309-19. 10.55563\/clinexprheumatol\/8xj0b9","journal-title":"Clin Exp Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab247.029","article-title":"Increased incidence of anti-synthetase syndrome during COVID-19 pandemic","volume":"60","author":"Phillips B","year":"2021","unstructured":"Phillips B, Martin J, Rhys-Dillon C. Increased incidence of anti-synthetase syndrome during COVID-19 pandemic. Rheumatology (Oxford). 2021, 60:keab247.029. 10.1093\/rheumatology\/keab247.029","journal-title":"Rheumatology (Oxford)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/77.1.1019","article-title":"Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes","volume":"77","author":"Marguerie C","year":"1990","unstructured":"Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK, Walport MJ. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med. 1990, 77:1019-38. 10.1093\/qjmed\/77.1.1019","journal-title":"Q J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25084453","article-title":"A review of antisynthetase syndrome-associated interstitial lung disease","volume":"25","author":"Patel P","year":"2024","unstructured":"Patel P, Marinock JM, Ajmeri A, Brent LH. A review of antisynthetase syndrome-associated interstitial lung disease. Int J Mol Sci. 2024, 25:10.3390\/ijms25084453","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae403","article-title":"Management and outcomes of interstitial lung disease associated with anti-synthetase syndrome: a systematic literature review","volume":"64","author":"Kouranloo K","year":"2025","unstructured":"Kouranloo K, Dey M, Elwell H, Yioe V, Spencer LG, Cotton CV. Management and outcomes of interstitial lung disease associated with anti-synthetase syndrome: a systematic literature review. Rheumatology (Oxford). 2025, 64:45-55. 10.1093\/rheumatology\/keae403","journal-title":"Rheumatology (Oxford)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.959653","article-title":"A multidisciplinary approach to the diagnosis of antisynthetase syndrome","volume":"9","author":"Wells M","year":"2022","unstructured":"Wells M, Alawi S, Thin KY, et al.. A multidisciplinary approach to the diagnosis of antisynthetase syndrome. Front Med (Lausanne). 2022, 9:959653. 10.3389\/fmed.2022.959653","journal-title":"Front Med (Lausanne)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez504","article-title":"The myositis clinical phenotype associated with anti-Zo autoantibodies: a case series of nine UK patients","volume":"59","author":"Tansley SL","year":"2020","unstructured":"Tansley SL, Betteridge Z, Lu H, et al.. The myositis clinical phenotype associated with anti-Zo autoantibodies: a case series of nine UK patients. Rheumatology (Oxford). 2020, 59:1626-31. 10.1093\/rheumatology\/kez504","journal-title":"Rheumatology (Oxford)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/art.43038","article-title":"Clinical characteristics of anti-synthetase syndrome: analysis from the classification criteria for anti-synthetase syndrome project","volume":"77","author":"Faghihi-Kashani S","year":"2025","unstructured":"Faghihi-Kashani S, Yoshida A, Bozan F, et al.. Clinical characteristics of anti-synthetase syndrome: analysis from the classification criteria for anti-synthetase syndrome project. Arthritis Rheumatol. 2025, 77:477-89. 10.1002\/art.43038","journal-title":"Arthritis Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.220139","article-title":"Coexistence of anti-Ro52 antibodies in anti-MDA5 antibody-positive dermatomyositis is highly associated with rapidly progressive interstitial lung disease and mortality risk","volume":"50","author":"Lv C","year":"2023","unstructured":"Lv C, You H, Xu L, et al.. Coexistence of anti-Ro52 antibodies in anti-MDA5 antibody-positive dermatomyositis is highly associated with rapidly progressive interstitial lung disease and mortality risk. J Rheumatol. 2023, 50:219-26. 10.3899\/jrheum.220139","journal-title":"J Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/0970-2113.173055","article-title":"Antisynthetase syndrome: an under-recognized cause of interstitial lung disease","volume":"33","author":"Maturu VN","year":"2016","unstructured":"Maturu VN, Lakshman A, Bal A, et al.. Antisynthetase syndrome: an under-recognized cause of interstitial lung disease. Lung India. 2016, 33:20-6. 10.4103\/0970-2113.173055","journal-title":"Lung India"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12950-024-00422-w","article-title":"Macrophage involvement in idiopathic inflammatory myopathy: pathogenic mechanisms and therapeutic prospects","volume":"21","author":"Li Z","year":"2024","unstructured":"Li Z, Liu H, Xie Q, Yin G. Macrophage involvement in idiopathic inflammatory myopathy: pathogenic mechanisms and therapeutic prospects. J Inflamm (Lond). 2024, 21:48. 10.1186\/s12950-024-00422-w","journal-title":"J Inflamm (Lond)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev004","article-title":"Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease","volume":"54","author":"Andersson H","year":"2015","unstructured":"Andersson H, Sem M, Lund MB, et al.. Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease. Rheumatology (Oxford). 2015, 54:1420-8. 10.1093\/rheumatology\/kev004","journal-title":"Rheumatology (Oxford)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2023-002076","article-title":"Association of anti-Ro52 autoantibody with interstitial lung disease in autoimmune diseases: a systematic review and meta-analysis","volume":"10","author":"Nayebirad S","year":"2023","unstructured":"Nayebirad S, Mohamadi A, Yousefi-Koma H, et al.. Association of anti-Ro52 autoantibody with interstitial lung disease in autoimmune diseases: a systematic review and meta-analysis. BMJ Open Respir Res. 2023, 10:10.1136\/bmjresp-2023-002076","journal-title":"BMJ Open Respir Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/433951-anti-synthetase-syndrome-presenting-primarily-as-interstitial-lung-disease-in-a-young-adult-a-diagnostic-challenge-in-acute-medicine","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:32:17Z","timestamp":1763659937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/433951-anti-synthetase-syndrome-presenting-primarily-as-interstitial-lung-disease-in-a-young-adult-a-diagnostic-challenge-in-acute-medicine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.97344","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,20]]}}}